fluoropyrimidine, HER2-wanaagsan, oxaliplatin, Seagen Inc, tucatinib, Tukysa
Oggolaanshaha degdega ah waxaa siisa FDA si ay u siiso tucatinib leh trastuzumab kansarka mindhicirka
Bishii Febraayo 2023, Maamulka Cuntada iyo Dawooyinka (FDA) ayaa dardar galiyay oggolaanshaha tucatinib (Tukisa, Seagen Inc.) iyo trastuzumab ee daawaynta RAS-nooca duurjoogta ah ee HER2-positive kansarka mindhicirka oo faafay ama aan noqon karin rem.
fluoropyrimidine, Isgoyska Gastroesophageal (GEJ) adenocarcinoma, KEYTRUDA, Merck & Co, Pembrolizumab, Trastuzumab
Pembrolizumab waxay ka heshaa FDA oggolaansho degdeg ah kansarka caloosha ee HER2-positive
Ogosto 2021: Pembrolizumab (Keytruda, Merck & Co.) oo ay weheliso trastuzumab, fluoropyrimidine-, iyo kiimoterabi oo ay ku jirto platinum waxaa oggolaansho degdeg ah siiyay Maamulka Cuntada iyo Dawooyinka ee kuwa ugu horreeya ..
Bristol Myers Squibb, CHEKMATE-649, fluoropyrimidine, nivolumab, Cajiib, kiimoterabi oo ay ku jirto platinum
Nivolumab marka lagu daro kiimoteraabiga waxaa ansixiyay FDA kansarka caloosha ee metastatic iyo adenocarcinoma hunguriga
Ogosto 2021: Loogu talagalay kansarka caloosha ee horumarsan ama metastatic, kansarka isgoyska gaastroesophageal, iyo adenocarcinoma hunguriga, Maamulka Cuntada iyo Dawooyinka ayaa oggolaaday nivolumab (Opdivo, Shirkadda Bristol-Myers Squibb) oo ay weheliso ..